Newborn screening fact sheets.
Newborn screening fact sheets were last revised in 1996 by the American Academy of Pediatrics Committee on Genetics. This revision was prompted by advances in the field since 1996, including technologic innovations, as well as greater appreciation of ethical issues such as those surrounding informed consent. The following disorders are discussed in this revision of the newborn screening fact sheets: biotinidase deficiency, congenital adrenal hyperplasia, congenital hearing loss, congenital hypothyroidism, cystic fibrosis, galactosemia, homocystinuria, maple syrup urine disease, medium-chain acyl-coenzyme A dehydrogenase deficiency, phenylketonuria, sickle cell disease and other hemoglobinopathies, and tyrosinemia. A series of topics related to newborn screening is discussed in a companion publication to this electronic publication of the fact sheets (available at: www.pediatrics.org/cgi/content/full/118/3/1304). These topics are newborn screening as a public health system; factors contributing to the need for review of the newborn screening system; informed consent; tandem mass spectrometry; DNA analysis in newborn screening; status of newborn screening in the United States; and the effect of sample timing, preterm birth, diet, transfusion, and total parenteral nutrition on newborn screening results.
Kaye
Celia I
CI
Accurso
Frank
F
La Franchi
Stephen
S
Lane
Peter A
PA
Hope
Northrup
N
Sonya
Pang
P
G Bradley
Schaefer
S
Michele A
Lloyd-Puryear
LP
D001803:Blood Transfusion; D004247:DNA / Q000032:analysis; D004032:Diet; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis*; D007258:Informed Consent; D008403:Mass Screening; D015997:Neonatal Screening / Q000941:ethics / Q000379:methods; D047928:Premature Birth; D011634:Public Health
D004247:DNA